Review



microarray assay human genome u133 plus 2.0, genechip® 3’ expression array  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher microarray assay human genome u133 plus 2.0, genechip® 3’ expression array
    Microarray Assay Human Genome U133 Plus 2.0, Genechip® 3’ Expression Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microarray assay human genome u133 plus 2.0, genechip® 3’ expression array/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    microarray assay human genome u133 plus 2.0, genechip® 3’ expression array - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    90
    Thermo Fisher microarray assay human genome u133 plus 2.0, genechip® 3’ expression array
    Microarray Assay Human Genome U133 Plus 2.0, Genechip® 3’ Expression Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microarray assay human genome u133 plus 2.0, genechip® 3’ expression array/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    microarray assay human genome u133 plus 2.0, genechip® 3’ expression array - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher genechip u133 plus 2.0 expression microarray
    (A) Schematic outline of the integrative epigenetic screening strategy utilized in this study which combined the pharmacologic demethylation of normal cell lines, comparative COPA anaylsis in primary tissue and correlation of gene expression with the epigenetic regulator BORIS in primary tissue. (B) Representative COPA graph of MAGEA12 demonstrating the statistical approach used to find candidate overexpressed CTAs and related genes. Difference in tumor versus normal expression was significant, p value<0.00001 as measured by Mann-Whitney U test. (C) Upfold regulation of mRNA expression in treated normal lung cell lines, NHBE and SAEC, as measured by Affymetrix Human Genome <t>U133</t> Plus 2.0 mRNA expression platform.
    Genechip U133 Plus 2.0 Expression Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/genechip u133 plus 2.0 expression microarray/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    genechip u133 plus 2.0 expression microarray - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher microarray assay human genome u133 plus 2.0, genechip ® 3' expression array
    (A) Schematic outline of the integrative epigenetic screening strategy utilized in this study which combined the pharmacologic demethylation of normal cell lines, comparative COPA anaylsis in primary tissue and correlation of gene expression with the epigenetic regulator BORIS in primary tissue. (B) Representative COPA graph of MAGEA12 demonstrating the statistical approach used to find candidate overexpressed CTAs and related genes. Difference in tumor versus normal expression was significant, p value<0.00001 as measured by Mann-Whitney U test. (C) Upfold regulation of mRNA expression in treated normal lung cell lines, NHBE and SAEC, as measured by Affymetrix Human Genome <t>U133</t> Plus 2.0 mRNA expression platform.
    Microarray Assay Human Genome U133 Plus 2.0, Genechip ® 3' Expression Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microarray assay human genome u133 plus 2.0, genechip ® 3' expression array/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    microarray assay human genome u133 plus 2.0, genechip ® 3' expression array - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher genechip u133 plus 2.0 genome wide expression cdna microarray
    (A) Schematic outline of the integrative epigenetic screening strategy utilized in this study which combined the pharmacologic demethylation of normal cell lines, comparative COPA anaylsis in primary tissue and correlation of gene expression with the epigenetic regulator BORIS in primary tissue. (B) Representative COPA graph of MAGEA12 demonstrating the statistical approach used to find candidate overexpressed CTAs and related genes. Difference in tumor versus normal expression was significant, p value<0.00001 as measured by Mann-Whitney U test. (C) Upfold regulation of mRNA expression in treated normal lung cell lines, NHBE and SAEC, as measured by Affymetrix Human Genome <t>U133</t> Plus 2.0 mRNA expression platform.
    Genechip U133 Plus 2.0 Genome Wide Expression Cdna Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/genechip u133 plus 2.0 genome wide expression cdna microarray/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    genechip u133 plus 2.0 genome wide expression cdna microarray - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher genechip human genome u133 plus 2.0 oligonucleotide expression microarrays
    (A) Schematic outline of the integrative epigenetic screening strategy utilized in this study which combined the pharmacologic demethylation of normal cell lines, comparative COPA anaylsis in primary tissue and correlation of gene expression with the epigenetic regulator BORIS in primary tissue. (B) Representative COPA graph of MAGEA12 demonstrating the statistical approach used to find candidate overexpressed CTAs and related genes. Difference in tumor versus normal expression was significant, p value<0.00001 as measured by Mann-Whitney U test. (C) Upfold regulation of mRNA expression in treated normal lung cell lines, NHBE and SAEC, as measured by Affymetrix Human Genome <t>U133</t> Plus 2.0 mRNA expression platform.
    Genechip Human Genome U133 Plus 2.0 Oligonucleotide Expression Microarrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/genechip human genome u133 plus 2.0 oligonucleotide expression microarrays/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    genechip human genome u133 plus 2.0 oligonucleotide expression microarrays - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher genechip human genome u133 plus 2.0 expression microarray
    (A) Schematic outline of the integrative epigenetic screening strategy utilized in this study which combined the pharmacologic demethylation of normal cell lines, comparative COPA anaylsis in primary tissue and correlation of gene expression with the epigenetic regulator BORIS in primary tissue. (B) Representative COPA graph of MAGEA12 demonstrating the statistical approach used to find candidate overexpressed CTAs and related genes. Difference in tumor versus normal expression was significant, p value<0.00001 as measured by Mann-Whitney U test. (C) Upfold regulation of mRNA expression in treated normal lung cell lines, NHBE and SAEC, as measured by Affymetrix Human Genome <t>U133</t> Plus 2.0 mRNA expression platform.
    Genechip Human Genome U133 Plus 2.0 Expression Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/genechip human genome u133 plus 2.0 expression microarray/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    genechip human genome u133 plus 2.0 expression microarray - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher human u133 plus 2.0 genechip oligonucleotide expression microarrays
    (A) Schematic outline of the integrative epigenetic screening strategy utilized in this study which combined the pharmacologic demethylation of normal cell lines, comparative COPA anaylsis in primary tissue and correlation of gene expression with the epigenetic regulator BORIS in primary tissue. (B) Representative COPA graph of MAGEA12 demonstrating the statistical approach used to find candidate overexpressed CTAs and related genes. Difference in tumor versus normal expression was significant, p value<0.00001 as measured by Mann-Whitney U test. (C) Upfold regulation of mRNA expression in treated normal lung cell lines, NHBE and SAEC, as measured by Affymetrix Human Genome <t>U133</t> Plus 2.0 mRNA expression platform.
    Human U133 Plus 2.0 Genechip Oligonucleotide Expression Microarrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human u133 plus 2.0 genechip oligonucleotide expression microarrays/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    human u133 plus 2.0 genechip oligonucleotide expression microarrays - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic outline of the integrative epigenetic screening strategy utilized in this study which combined the pharmacologic demethylation of normal cell lines, comparative COPA anaylsis in primary tissue and correlation of gene expression with the epigenetic regulator BORIS in primary tissue. (B) Representative COPA graph of MAGEA12 demonstrating the statistical approach used to find candidate overexpressed CTAs and related genes. Difference in tumor versus normal expression was significant, p value<0.00001 as measured by Mann-Whitney U test. (C) Upfold regulation of mRNA expression in treated normal lung cell lines, NHBE and SAEC, as measured by Affymetrix Human Genome U133 Plus 2.0 mRNA expression platform.

    Journal: PLoS ONE

    Article Title: Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC

    doi: 10.1371/journal.pone.0008189

    Figure Lengend Snippet: (A) Schematic outline of the integrative epigenetic screening strategy utilized in this study which combined the pharmacologic demethylation of normal cell lines, comparative COPA anaylsis in primary tissue and correlation of gene expression with the epigenetic regulator BORIS in primary tissue. (B) Representative COPA graph of MAGEA12 demonstrating the statistical approach used to find candidate overexpressed CTAs and related genes. Difference in tumor versus normal expression was significant, p value<0.00001 as measured by Mann-Whitney U test. (C) Upfold regulation of mRNA expression in treated normal lung cell lines, NHBE and SAEC, as measured by Affymetrix Human Genome U133 Plus 2.0 mRNA expression platform.

    Article Snippet: We carried out oligonucleotide microarray analysis using the GeneChip U133 Plus 2.0 Affymetrix expression microarray (Affymetrix, Santa Clara, CA).

    Techniques: Expressing, MANN-WHITNEY

    (A) Heat map of transcript expression as measured by the Affymetrix Human Genome U133 Plus 2.0 mRNA expression platform. The data were first normalized by setting the mean and standard deviation of each gene to 0 and 1 respectively across all 151 samples. The data were then clustered in the sample domain using hierarchical clustering with average linkage and a Euclidean distance metric. (B) Pearson's correlation coefficient p-value matrix for gene expression which tests for the coexpression of each gene pair across all tumors. This comparison shows the expression correlation of each gene pair in 111 NSCLC. Values to the upper right have been corrected with the Benjamin Hochberg multiple test correction to decrease the false discovery rate; uncorrected values are displayed in the lower left. Shaded cells represent significant p-values.

    Journal: PLoS ONE

    Article Title: Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC

    doi: 10.1371/journal.pone.0008189

    Figure Lengend Snippet: (A) Heat map of transcript expression as measured by the Affymetrix Human Genome U133 Plus 2.0 mRNA expression platform. The data were first normalized by setting the mean and standard deviation of each gene to 0 and 1 respectively across all 151 samples. The data were then clustered in the sample domain using hierarchical clustering with average linkage and a Euclidean distance metric. (B) Pearson's correlation coefficient p-value matrix for gene expression which tests for the coexpression of each gene pair across all tumors. This comparison shows the expression correlation of each gene pair in 111 NSCLC. Values to the upper right have been corrected with the Benjamin Hochberg multiple test correction to decrease the false discovery rate; uncorrected values are displayed in the lower left. Shaded cells represent significant p-values.

    Article Snippet: We carried out oligonucleotide microarray analysis using the GeneChip U133 Plus 2.0 Affymetrix expression microarray (Affymetrix, Santa Clara, CA).

    Techniques: Expressing, Standard Deviation